Observatory · observe first

Follow the allocation change

Matched S&P 500 members → sector → industry → sub-industry → company. Each step uses the same percentage points.

Historical time machine

Historical observation

20182026

Universe›Health Care›Pharmaceuticals›Pharmaceuticals

1 · Sector

Weight and 12M allocation change

Information Technology28.6%+15.24 pp Health Care16.6%+8.70 pp Financials13.3%+6.14 pp Industrials10.2%+4.03 pp Consumer Staples7.5%+3.95 pp Energy3.1%+1.92 pp Real Estate3.2%+1.74 pp Utilities3.2%+1.64 pp Materials3.2%+1.62 pp Communication Services3.9%+1.42 pp Consumer Discretionary7.2%-46.41 pp

2 · Industry

Inside Health Care

Pharmaceuticals4.80%+2.43 pp Health Care Equipment3.31%+1.65 pp Managed Health Care2.29%+1.35 pp Biotechnology2.39%+1.28 pp Life Sciences Tools & Services2.05%+1.06 pp Health Care Services0.90%+0.48 pp Health Care Distributors0.34%+0.20 pp Health Care Facilities0.26%+0.15 pp Health Care Supplies0.26%+0.12 pp Health Care Technology0.00%+0.00 pp

3 · Sub-industry

Inside Pharmaceuticals

Pharmaceuticals4.80%+2.426 pp

Broad

The gain is shared across much of the industry.

View all contributions →

Pharmaceuticals · weight

4.80%

Industry change · 12M

+2.43 pp

Pharmaceuticals · contribution

+2.426 pp

Company participation

43%

of industry constituents above their 6M weight average

4 · Companies driving this sub-industry

Feb 2022 · sorted by absolute contribution to 12-month change

Company	Country	Market cap	Universe weight	3M contribution	12M contribution	12M price return	Above 6M weight average
Johnson & Johnson → JNJ	United States	$432.7bn	1.501%	+0.114 pp	+0.668 pp	+6.5%	Yes
Pfizer → PFE	United States	$264.0bn	0.916%	-0.103 pp	+0.542 pp	+45.2%	No
Lilly (Eli) → LLY	United States	$238.0bn	0.826%	+0.024 pp	+0.433 pp	+23.8%	Yes
Merck & Co. → MRK	United States	$193.6bn	0.671%	+0.032 pp	+0.321 pp	+14.5%	No
Bristol Myers Squibb → BMY	United States	$149.7bn	0.519%	+0.117 pp	+0.245 pp	+15.6%	Yes
Zoetis → ZTS	United States	$91.4bn	0.317%	-0.038 pp	+0.170 pp	+25.4%	No
Viatris → VTRS	United States	$13.3bn	0.046%	-0.004 pp	+0.046 pp	-23.5%	No

Company contributions use weights among matched S&P 500 members and add through each level without rescaling. Companies without matched shares and prices are omitted. These observations do not establish official index weights or actual fund flows.